Similarly, SQLE is upregulated in nasopharyngeal cancer (13), head and neck squamous cell carcinoma (24), leukemia (25), hepatocellular cancer (26–28), and squamous lung cancer (29, 30). This evidence concerns the gene SQLE and head and neck squamous cell carcinoma.